POTENTIOMETRIC PROBES, LLC
Medtech · Private
Organic voltage-sensitive dyes (VSDs) that convert membrane voltage changes to fluorescent signals for optical recording of cardiac electrical activity
- Grants
- $2.8M
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20182019202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · High sensitivity tethered bichromophoric voltage-sensitive dyes | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Improved Ratiometric Voltage-Sensitive Dyes for In-Vitro and In-Vivo Imaging of Brain Electrical Signaling | $308,985 | |
| Federal grant | Department of Health and Human Services · Phase I · Improved Ratiometric Voltage-Sensitive Dyes for In-Vitro and In-Vivo Imaging of Brain Electrical Signaling | $141,015 | |
| Federal grant | Department of Health and Human Services · Phase II · Optimized Ratiometric Voltage-Sensitive Dyes for Cardiac Research, Safety Pharmacology | $958,484 | |
| Federal grant | Department of Health and Human Services · Phase I · A Palette of Near-Infrared Voltage Sensors for Cardiac Research and Safety Pharmacology | $282,266 | |
| Federal grant | Department of Health and Human Services · Phase II · Optimized Ratiometric Voltage-Sensitive Dyes for Cardiac Research, Safety Pharmacology | $929,918 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1307 | Cytrellis Biosystems, Inc. | — | $83M |
| 1308 | NANOCRINE, INC. | — | — |
| 1309 | BRIUS Technologies, Inc. | — | $21M |
| 1310 | POTENTIOMETRIC PROBES, LLC | — | — |
| 1311 | LASER BIOANALYTICS LLC | — | — |
| 1312 | INANOVATE INC | — | $13M |
| 1313 | Optain Health, Inc. | — | $31M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.